NHI — National Health Investors Income Statement

0.000.00%

Last trade - 00:00

FinancialsConservativeLarge CapNeutral

Annual income statement for National Health Investors, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	299	278	320	335	376
Cost of Revenue
Gross Profit	287	240	269	282	304
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	218	242	201	212	239
Operating Profit	80.7	36.6	119	123	137
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	112	65.5	134	137	141
Net Income After Taxes	112	65.5	134	137	141
Minority Interest
Net Income Before Extraordinary Items
Net Income	112	66.4	136	138	142
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	112	66.4	136	138	142
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.93	2.23	2.82	3.09	2.95
Dividends per Share